REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Nyir-Pharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: NYIR-PHARMA Szolgaltato es Kereskedelmi Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Nyir-Pharma Bt. is a company in Hungary, with a head office in Nyirtass. It operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on May 01, 1996. 4 (2024) employees currently work for Nyir-Pharma Bt.. In 2023, the company reported a net sales revenue increase of 7.45%. Its’ total assets recorded a negative growth of 10.81%. Nyir-Pharma Bt.’s net profit margin decreased by 2.99% in 2023.

Headquarters
Dozsa ut 112.
Nyirtass; Szabolcs-Szatmar-Bereg; Postal Code: 4522

Contact Details: Purchase the Nyir-Pharma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Nyir-Pharma Bt. report to view the information.
Outstanding Shares:
Purchase the Nyir-Pharma Bt. report to view the information.
Registered Capital:
Purchase the Nyir-Pharma Bt. report to view the information.
Financial Auditors:
Purchase the Nyir-Pharma Bt. report to view the information.
Incorporation Date:
May 01, 1996
Key Executives
Purchase this report to view the information.
Business Manager
Purchase this report to view the information.
Business Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Nyir-Pharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
7.45%▲
Total operating revenue
7.02%▲
Operating profit (EBIT)
-43.13%▼
EBITDA
-42.7%▼
Net Profit (Loss) for the Period
-42.74%▼
Total assets
-10.81%▼
Total equity
-19.32%▼
Operating Profit Margin (ROS)
-3.34%▼
Net Profit Margin
-2.99%▼
Return on Equity (ROE)
-13.12%▼
Quick Ratio
-0.3%▼
Cash Ratio
-1%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo